As shown in the sections above, TRX lowers lung damage in COPD by improving the balance between proteases and antiproteases, regulating oxidative stress and inflammation through transcription factors, including PI3-APK and NF-kB, and other mechanisms. The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.